Helus Pharma (HELP) vs Obsidian Therapeutics (OBX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Obsidian Therapeutics is the larger company by market cap ($815.4 million vs $767.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HELP | OBX |
|---|---|---|
| Share price | $10.51 | $13.20 |
| Market cap | $767.86M | $815.40M |
| 1-day change | -2.32% | -0.15% |
| YTD return | +28.48% | — |
| 1-year return | +73.15% | — |
| 5-year return | -85.96% | — |
| EPS (TTM) | $-4.15 | $-1.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.15 | $49.97 |
| 52-week low | $3.76 | $12.16 |
| Distance from 52-week high | -30.63% | -73.58% |
| Average volume | 1.79M | 364.58K |
| Shares outstanding | 73.06M | 61.77M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
HELP vs OBX FAQ
Which is bigger, Helus Pharma or Obsidian Therapeutics?
Obsidian Therapeutics (OBX) is larger, with a market capitalization of $815.40M compared with $767.86M for Helus Pharma (HELP).
Are Helus Pharma and Obsidian Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.